Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS

6.45 Down 0.04(0.54%) 4:00PM EDT|After Hours : 6.46 Up 0.02 (0.23%) 4:04PM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 3,428   4,399   1,231  
Cost of Revenue -   -   -  
Gross Profit 3,428   4,399   1,231  
Operating Expenses
Research Development73,680  12,780  28,131  
Selling General and Administrative19,987  19,502  24,495  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (90,239) (27,883) (51,395)
Income from Continuing Operations
Total Other Income/Expenses Net147  46  124  
Earnings Before Interest And Taxes(90,092)(27,837)(51,271)
Interest Expense2  221  644  
Income Before Tax(90,094)(28,058)(51,915)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(90,094)(28,058)(51,915)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (90,094) (28,058) (51,915)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (90,094) (28,058) (51,915)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.